Skip to main content
. 2024 Jan 16;8(3):493–509. doi: 10.1038/s41562-023-01787-3

Table 3.

Between-group effect sizes of depressive and anxiety symptoms for transdiagnostic treatments compared to control groups at follow-up

Depression Anxiety
k g P LL UL I2 Q P k g P LL UL I2 Q P
3month FU TD-CBT (all treatment formats) versus Control 29 0.55 <0.001 0.30 0.80 89.98 143.19 <0.001 24 0.48 0.002 0.18 0.79 92.31 131.28 <0.001
DS-CBT 5 0.11 0.376 −0.14 0.37 77.81 15.73 0.003 5 −0.01 0.912 −0.18 0.16 52.62 8.48 0.075
TAU 6 0.42 <0.001 0.26 0.59 6.45 6.77 0.238 4 0.49 <0.001 0.22 0.76 51.43 6.24 0.101
Other 10 0.33 0.014 0.07 0.59 57.15 20.99 0.013 8 0.24 0.009 0.06 0.42 0 9.69 0.207
WL 8 1.29 0.002 0.47 2.10 93.43 70.96 <0.001 7 1.31 0.016 0.24 2.37 94.84 77.31 <0.001
Individual TD-CBT versus Control 8 1.38 <0.001 0.64 2.13 90.69 51.37 <0.001 5 1.88 0.002 0.72 3.03 91.25 50.83 <0.001
Group-based TD-CBT versus Control 12 0.39 0.002 0.14 0.63 74.49 31.78 <0.001 10 0.42 <0.001 0.20 0.65 61.80 22.45 0.008
Internet-based TD-CBT versus Control 9 0.18 0.127 −0.05 0.42 73.17 27.64 <0.001 9 −0.05 0.409 −0.17 0.07 2.55 7.89 0.444
6month FU TD-CBT (all treatment formats) versus Control 17 0.20 <0.001 0.10 0.30 17.75 24.09 0.088 19 0.23 <0.001 0.11 0.36 42.99 34.74 0.010
DS-CBT 3 −0.01 0.937 −0.23 0.21 39.89 3.28 0.194 3 0.04 0.650 −0.15 0.24 22.99 2.33 0.312
TAU 4 0.26 <0.001 0.15 0.38 0 0.74 0.864 4 0.32 0.001 0.13 0.52 47.22 5.67 0.129
Other 7 0.15 0.163 −0.06 0.37 10.92 6.13 0.409 8 0.19 0.050 0 0.38 0 6.19 0.518
WL 3 0.63 0.019 0.10 1.15 47.71 3.82 0.148 4 0.62 0.065 −0.04 1.27 77.44 11.90 0.008
Individual TD-CBT versus Control 9 0.24 0.012 0.05 0.44 44.45 14.07 0.080 10 0.28 <0.001 0.18 0.38 0 18.92 0.026
Group-based TD-CBT versus Control 8 0.16 0.033 0.01 0.31 16.49 9.45 0.222 9 0.17 0.065 −0.01 0.36 46.53 14.41 0.072
Internet-based TD-CBT versus Control
12month FU TD-CBT (all treatment formats) versus Control 11 0.24 <0.001 0.13 0.35 33.53 13.48 0.198 11 0.22 <0.001 0.12 0.32 24.83 10.52 0.396
DS-CBT 4 0.13 0.247 −0.09 0.36 58.91 7.48 0.058 4 0.08 0.253 −0.06 0.23 0 0.87 0.832
TAU 4 0.35 <0.001 0.24 0.47 0 0.30 0.960 4 0.36 <0.001 0.24 0.48 0 0.70 0.872
Other 3 0.23 0.030 0.02 0.44 0 0.03 0.985 3 0.21 0.044 0.01 0.42 0 0.10 0.950
WL
Individual TD-CBT versus Control 3 0.33 <0.001 0.21 0.45 0 0.58 0.748 3 0.34 <0.001 0.20 0.47 9.71 1.67 0.434
Group-based TD-CBT versus Control 3 0.30 0.006 0.09 0.51 0 0.59 0.745 3 0.27 0.012 0.06 0.48 0 0.24 0.888
Internet-based TD-CBT versus Control 5 0.17 0.098 −0.03 0.38 54.63 8.93 0.063 5 0.11 0.116 −0.03 0.24 0 1.95 0.746
24month FU TD-CBT (all treatment formats) versus Control 5 0.20 0.111 −0.05 0.46 80.63 16.44 0.003 5 0.14 0.092 −0.02 0.31 56.46 8.63 0.071
DS-CBT 4 0.20 0.259 −0.14 0.54 81.90 16.15 0.001 4 0.11 0.344 −0.12 0.35 62.33 8.25 0.041
TAU
Other
WL
Individual TD-CBT versus Control
Group-based TD-CBT versus Control
Internet-based TD-CBT versus Control 4 0.20 0.259 −0.14 0.54 81.90 16.15 0.001 4 0.11 0.344 −0.12 0.35 62.33 8.25 0.041

FU, follow-up.